These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 24990531)

  • 1. The evolving role of chemical synthesis in antibacterial drug discovery.
    Wright PM; Seiple IB; Myers AG
    Angew Chem Int Ed Engl; 2014 Aug; 53(34):8840-69. PubMed ID: 24990531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2012 Garrod lecture: discovery of antibacterial drugs in the 21st century.
    Chopra I
    J Antimicrob Chemother; 2013 Mar; 68(3):496-505. PubMed ID: 23134656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A platform for the discovery of new macrolide antibiotics.
    Seiple IB; Zhang Z; Jakubec P; Langlois-Mercier A; Wright PM; Hog DT; Yabu K; Allu SR; Fukuzaki T; Carlsen PN; Kitamura Y; Zhou X; Condakes ML; Szczypiński FT; Green WD; Myers AG
    Nature; 2016 May; 533(7603):338-45. PubMed ID: 27193679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A synthetic antibiotic class overcoming bacterial multidrug resistance.
    Mitcheltree MJ; Pisipati A; Syroegin EA; Silvestre KJ; Klepacki D; Mason JD; Terwilliger DW; Testolin G; Pote AR; Wu KJY; Ladley RP; Chatman K; Mankin AS; Polikanov YS; Myers AG
    Nature; 2021 Nov; 599(7885):507-512. PubMed ID: 34707295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems-Level Chemical Biology to Accelerate Antibiotic Drug Discovery.
    Farha MA; French S; Brown ED
    Acc Chem Res; 2021 Apr; 54(8):1909-1920. PubMed ID: 33787225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic Immunobiotics: A Future Success Story in Small Molecule-Based Immunotherapy?
    Feigman MJS; Pires MM
    ACS Infect Dis; 2018 May; 4(5):664-672. PubMed ID: 29431421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antibacterial activity of novel bifunctional macrolides.
    Akritopoulou-Zanze I; Phelan KM; Marron TG; Yong H; Ma Z; Stone GG; Daly MM; Hensey DM; Nilius AM; Djuric SW
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3809-13. PubMed ID: 15203167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
    Konreddy AK; Rani GU; Lee K; Choi Y
    Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial agents from actinomycetes - a review.
    Mahajan GB; Balachandran L
    Front Biosci (Elite Ed); 2012 Jan; 4(1):240-53. PubMed ID: 22201868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Antibacterial Compounds and their Drug Targets - Successes and Challenges.
    Kaczor AA; Polski A; Sobótka-Polska K; Pachuta-Stec A; Makarska-Bialokoz M; Pitucha M
    Curr Med Chem; 2017; 24(18):1948-1982. PubMed ID: 27978802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Antibacterials: Alternatives to Traditional Antibiotics.
    Betts JW; Hornsey M; La Ragione RM
    Adv Microb Physiol; 2018; 73():123-169. PubMed ID: 30262108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.
    Viganor L; Howe O; McCarron P; McCann M; Devereux M
    Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of SBDD to the discovery of new antibacterial drugs.
    Finn J
    Methods Mol Biol; 2012; 841():291-319. PubMed ID: 22222458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibacterial drug discovery in the resistance era.
    Brown ED; Wright GD
    Nature; 2016 Jan; 529(7586):336-43. PubMed ID: 26791724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical philanthropy: a path forward for antibiotic discovery?
    Hansford KA; Blaskovich MA; Cooper MA
    Future Med Chem; 2016 Jun; 8(9):925-9. PubMed ID: 27228160
    [No Abstract]   [Full Text] [Related]  

  • 16. Discovery of Macrolide Antibiotics Effective against Multi-Drug Resistant Gram-Negative Pathogens.
    Myers AG; Clark RB
    Acc Chem Res; 2021 Apr; 54(7):1635-1645. PubMed ID: 33691070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using experimental evolution to identify druggable targets that could inhibit the evolution of antimicrobial resistance.
    Mehta HH; Prater AG; Shamoo Y
    J Antibiot (Tokyo); 2018 Feb; 71(2):279-286. PubMed ID: 28928474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytochemical conjugation as a potential semisynthetic approach toward reactive and reuse of obsolete sulfonamides against pathogenic bacteria.
    Swain SS; Paidesetty SK; Padhy RN
    Drug Dev Res; 2021 Apr; 82(2):149-166. PubMed ID: 33025605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial and antioxidant activities for natural and synthetic dual-active compounds.
    Martelli G; Giacomini D
    Eur J Med Chem; 2018 Oct; 158():91-105. PubMed ID: 30205261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenazine antibiotic inspired discovery of potent bromophenazine antibacterial agents against Staphylococcus aureus and Staphylococcus epidermidis.
    Borrero NV; Bai F; Perez C; Duong BQ; Rocca JR; Jin S; Huigens RW
    Org Biomol Chem; 2014 Feb; 12(6):881-6. PubMed ID: 24389824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.